SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-011997
Filing Date
2020-06-29
Accepted
2020-06-29 06:07:55
Documents
74
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 752701
2 ex10-53.htm EX-10.53 105396
3 ex31-1.htm EX-31.1 22387
4 ex31-2.htm EX-31.2 21570
5 ex32-1.htm EX-32.1 6148
6 ex32-2.htm EX-32.2 6011
  Complete submission text file 0001493152-20-011997.txt   5669139

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE matn-20200331.xml EX-101.INS 920345
8 XBRL SCHEMA FILE matn-20200331.xsd EX-101.SCH 68689
9 XBRL CALCULATION FILE matn-20200331_cal.xml EX-101.CAL 53983
10 XBRL DEFINITION FILE matn-20200331_def.xml EX-101.DEF 365062
11 XBRL LABEL FILE matn-20200331_lab.xml EX-101.LAB 434109
12 XBRL PRESENTATION FILE matn-20200331_pre.xml EX-101.PRE 411977
Mailing Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301
Business Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301 650-635-7000
MATEON THERAPEUTICS INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21990 | Film No.: 20995846
SIC: 2834 Pharmaceutical Preparations